NASDAQ · COOHealthcareOphthalmic Goods

The Cooper Companies, Inc. Common Stock (COO)

$63.51−1.41%
Close Nov 5, 2026 · split-adjusted
Nov 4, 2026$64.42▼ 6.75% in range
Nov 4, 2025Low $53.27 · High $84.32Nov 4, 2026
What changed · written from our data
As of Nov 5, 2026

The Cooper Companies closed at $63.51 on Nov 5, down 1.41%, 24.7% below its 52-week closing high. Volume of 2.4M shares was 0.75× its 20-day average (below normal).

Split-adjusted performance: +16.0% over one month, +3.9% over six months, -8.1% over one year.

In the quarter ended Jul 31, 2026, revenue was $1.07B, up 0.6% from a year earlier, with a net margin of 40.6%.

Short interest was 9.1M shares at the Oct 15 settlement, up 9.1% from the prior report (4.9% of float, 2.4 days to cover).

Market cap$12.08B190.2M shares
Revenue · quarter$1.07B+0.6% YoY
Diluted EPS$2.24+357.1% YoY
P/E · TTM21.2×P/S 2.9×
Net margin40.6%Gross 66.8%
Dividend yieldNone$0.03 last paid
52-week range53.27 – 84.32−24.7% from high
Volume2.4M0.75× 20-day avg
Volatility · 60d45.1%Annualised
Short % of float4.9%2.4 days to cover
Net cash-$2.39BCash $154.7M
Next earnings—Not scheduled
Split-adjusted performance
1W +5.3%1M +16.0%3M −14.4%6M +3.9%YTD −22.5%1Y −8.1%3Y −18.5%5Y −39.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Ophthalmic Goods

Percentile among 7 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −4.1%, revenue growth +2.5%, net margin 2.3%, P/E 222.2×.

Short interest

Details →
Shares short9.1M+9.1% vs prior
Days to cover2.4Settled Oct 15
% of float4.9%
Short vol. 10d33.7%of daily volume

Closest peers by size in Ophthalmic Goods

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
COOThe Cooper Companies$63.51−1.41%+3.9%+0.6%40.6%21.2$12.08B
BLCOBausch + Lomb$19.92−3.30%+25.2%+7.3%2.3%—$7.12BCompare
WRBYWarby Parker$26.08+22.50%−4.1%+9.8%2.0%416.4$3.22BCompare
EYENational Vision Holdings$17.85−0.50%−21.8%+2.5%2.5%28.1$1.41BCompare
STAAStaar Surgical Co$26.72−1.66%−2.1%−12.0%6.7%2,528.0$1.34BCompare
RXSTRxSight$4.54−9.02%−21.7%−19.0%−66.2%—$190.4MCompare
LUCYInnovative Eyewear$0.8210−2.69%−21.8%+74.5%−165.3%—$7.2MCompare

Quick answers

What does The Cooper Companies do?
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical.
What is COO's market cap?
$12.08B, based on the Nov 5 close of $63.51.
What is COO's P/E ratio?
21.2× trailing-twelve-month earnings of $570.30M.
Does The Cooper Companies pay a dividend?
No regular cash dividend has been paid in the last year.
How much of COO is sold short?
9.1M shares, 4.9% of float, as of Oct 15, 2026.
What sector is COO in?
Healthcare, in the Ophthalmic Goods industry.

About The Cooper Companies

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

HQ: San Ramon, CA15,000 employeesListed Jan 21, 1983coopercos.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology